Correlation Between PDS Biotechnology and Apollo Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Apollo Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Apollo Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Apollo Medical Holdings, you can compare the effects of market volatilities on PDS Biotechnology and Apollo Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Apollo Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Apollo Medical.

Diversification Opportunities for PDS Biotechnology and Apollo Medical

-0.05
  Correlation Coefficient

Good diversification

The 3 months correlation between PDS and Apollo is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Apollo Medical Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apollo Medical Holdings and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Apollo Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apollo Medical Holdings has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Apollo Medical go up and down completely randomly.

Pair Corralation between PDS Biotechnology and Apollo Medical

Assuming the 90 days horizon PDS Biotechnology Corp is expected to under-perform the Apollo Medical. In addition to that, PDS Biotechnology is 2.39 times more volatile than Apollo Medical Holdings. It trades about -0.24 of its total potential returns per unit of risk. Apollo Medical Holdings is currently generating about -0.16 per unit of volatility. If you would invest  3,580  in Apollo Medical Holdings on October 9, 2024 and sell it today you would lose (500.00) from holding Apollo Medical Holdings or give up 13.97% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

PDS Biotechnology Corp  vs.  Apollo Medical Holdings

 Performance 
       Timeline  
PDS Biotechnology Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Apollo Medical Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apollo Medical Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

PDS Biotechnology and Apollo Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PDS Biotechnology and Apollo Medical

The main advantage of trading using opposite PDS Biotechnology and Apollo Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Apollo Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apollo Medical will offset losses from the drop in Apollo Medical's long position.
The idea behind PDS Biotechnology Corp and Apollo Medical Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Commodity Directory
Find actively traded commodities issued by global exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance